Australia's Nova Eye Medical surges on record annual revenue

Nova Eye Medical

29/07/2025 02:23

** Shares of Nova Eye Medical EYE.AX rise as much as nearly 17% to A$0.170, their highest level since Jan 28

** Medical tech co posts record FY25 revenue in-line with guidance

** Its glaucoma segment generates positive EBITDA in second-half

** Co expects to break even EBITDA in FY26H1

** YTD, shares down 9.4% as of last close

($1 = 1.5352 Australian dollars)

 (Reporting by Nichiket Sunil in Bengaluru)

 ((Nichiket.Sunil@thomsonreuters.com))